NICOLETTE VANMALDEGHEM: Open Payments
NPI 1538828223 · STERLING HEIGHTS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$914 in 38 payments from 8 companies in 2025. Trend: 2023 $133 · 2024 $1,273 · 2025 $914
Food & beverage: $914
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $461 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $192 |
| Janssen Biotech, Inc. | 4 | $96 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $72 |
| Ardelyx, Inc. | 2 | $30 |
| QOL Medical, LLC | 1 | $26 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| Organon LLC | 1 | $18 |
Products named: LINZESS, XIFAXAN, RINVOQ, TREMFYA, EOHILIA, SKYRIZI, IBSRELA, Sucraid.
Industry payments across MI — which companies pay providers there.
